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ABSTRACT
Objectives: Intrahepatic cholestasis of pregnancy (ICP) is charachterized by pruritis 
and elevated serum bile acids (BA) and is associated with adverse obstetrical 
outcomes. ICP etiology is poorly understood and its incidence varies with ethnicity 
and geographical distribution. 
Objectives: Explore the prevalence and characteristics of ICP in the different 
Northern Israeli ethnic groups and compare maternal and perinatal outcomes 
according to disease severity.
Material and methods: Single-center retrospective study. Women who were 
diagnosed with ICP based on clinical presentation and elevated fasting BA (≥ 10 
μmol/L) were included. Disease incidence, maternal and neonatal complications were 
explored according to ethnic subgroups analysis and obstetrical complications were 
examined according to disease severity.
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Results: The incidence of ICP in the study population was 0.58%. Higher ICP 
incidence was found in our cohort compared with other reports arising from Central 
Israel (p < 0.001). The Christian patients had a higher incidence of ICP (1.1%) and 
preeclampsia (23.1%). A higher rate of neonatal intensive care unit (NICU) 
admissions was found in the Arab Muslim and Christian groups compared with the 
Jewish and Druze groups (p = 0.007). 
A higher rate of preeclampsia was found in the severe (BA ≥ 40 μmol/L) ICP group (p
< 0.001). Patients in the severe ICP group had earlier gestational age at delivery (37 
versus 38.14 weeks, p < 0.001). Birth weight was significantly lower in the severe 
ICP group (p = 0.018).
Conclusions: The incidence of ICP at our institution was 0.58%, which is higher 
compared with previous reported Israeli incidence. Higher ICP and preeclampsia 
incidence were found among Arab Christian patients. 
Keywords: intrapartum cholestasis of pregnancy; ethnicity; retrospective cohort 
review; maternal outcome; perinatal outcome
INTRODUCTION
Intrahepatic cholestasis of pregnancy (ICP) is a cholestatic disorder 
characterized by pruritus with increased serum bile acids (BA) and elevated serum 
aminotransferases. ICP manifests in the second half of pregnancy and rapidly resolves
after delivery. It is associated with increased rates of fetal morbidity and mortality. It 
increases the risk of preterm delivery, meconium-stained amniotic fluid and fetal 
distress [1, 2]. Higher total serum bile acid levels are associated with higher rates of 
fetal complications, and severe cholestasis is defined as bile acids over 40 μmol/L [3].
There is significant geographical and ethnical variation in the incidence of ICP
which suggest a genetic predisposition. For instance, in certain areas of Chile, rates 
have been reported up to 22% [4], while the rates from France and the United 
Kingdom are less than 1% [5]. Recent studies emerging from Central Israel have 
reported an incidence of 0.1–0.36% for ICP, but ethnical charataristics have not been 
studied before [6, 7]. 
2
Compared with Central Israel, Northern Israel consists of a widely diverse 
population which includes several ethnic groups with unique genetic makeup. This 
study was conducted in the Galilee Medical Center in Nahariya, located in Northern 
Israel, which serves a population of over 600,000 comprising of Jews, as well as 
Christian and Muslim Arabs and Druze. Our study sought to investigate the 
prevalence and characteristics of ICP in the different Northern ethnic populations and 
to compare its incidence with Central Israel. Additionally, we aimed to compare 
maternal and perinatal outcomes between mild and severe disease.
MATERIAL AND METHODS
Study design
We conducted a historical cohort study of women diagnosed with ICP.
Study population 
Women hospitalized between April 2013 and December 2017 in the Galilee 
Medical Center (Nahariya, Northern Israel) with a diagnosis of ICP were included in 
the study group.
We excluded women without a definitive diagnosis of ICP or missing 
information on pregnancy outcome.
Data collection 
Demographic, clinical, obstetrical and laboratory data were collected from 
computerized medical records and the hospital’s laboratory database. 
Maternal data included: age, gravidity, parity, mode of conception, multiple 
pregnancy, ethnicity (Jews, Arab Christian, Arab Muslim, Druze), gestational age at 
diagnosis and at delivery, medications, comorbidities including pre-gestational 
diabetes mellitus, chronic hypertension, thrombophilia and any other renal, liver or 
cardiac disease. Data concerning current pregnancy complications included: rates of 
preeclampsia (PET), oligohydramnios, polyhydramnios, premature uterine 
contractions and gestational diabetes. Laboratory parameters included serum levels of 
alanine aminotransferase (ALT) and fasting total BA.
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Data concerning the course of labor was collected: onset of labor 
(spontaneous/iatrogenic), gestational age at delivery, mode of delivery, rate of preterm
delivery (spontaneous or iatrogenic), postpartum hemorrhage (PPH), meconium-
stained amniotic fluid, non-reassuring fetal monitoring. 
Neonatal data included: gender, birthweight and birthweight percentile—
which was calculated according to Dolberg fetal growth calculator [8], Apgar score at 
1 and 5 min, arterial umbilical cord pH, neonatal intensive care (NICU) admission, 
respiratory complications (respiratory distress syndrome, transient tachypnea of 
newborn, ventilation, respiratory support), hypoglycemia, hyperbilirubinemia, anemia
and perinatal mortality. In addition, pediatric emergency department (ED) visits 
during the neonatal period were examined 
Definitions
ICP was defined as a combination of pruritus and an increased fasting serum 
BA ≥ 10 μmol/L, while other causes of itching and liver dysfunction were excluded. 
Severe ICP was defined by fasting serum BA ≥ 40 μmol/L.
PET was diagnosed by the combination of new-onset hypertension and 
proteinuria after 20 weeks of gestation.  Elevated blood pressure was defined as 
systolic blood pressure of 140 mmHg or more or diastolic blood pressure of 90 mm 
Hg or more on two occasions at least four hours apart and proteinuria as 300 mg 
protein or more per 24-hour urine collection. 
Postpartum hemorrhage was defined as estimated blood loss of ≥ 500 mL in the 24 h 
after vaginal delivery or ≥ 1000 ml after cesarean delivery.
Spontaneous delivery versus iatrogenic: according to our local management 
protocol of ICP and in line with accepted guidelines, iatrogenic induction of labor was
performed at 37 weeks of gestation if spontaneous delivery has not occurred and ICP 
was diagnosed before term.
Preterm delivery was defined as delivery < 37 gestational weeks (either spontaneous 
or iatrogenic).
Three types of cesarean deliveries (CD) were defined: elective CD was done 
for maternal or neonatal indications, without evidence for compromise of either one 
of them, (e.g., repeated cesarean sections) and was performed at its scheduled time. 
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Non-elective CD was carried out for maternal or fetal indications (e.g., ruptured 
membranes and breech presentation) and was not performed immediately. Emergency 
CD was performed immediately in cases of fetal or maternal compromise.
Small for gestational age (SGA) newborn was defined as birthweight below the 10th 
percentile according to local growth curves (Dolberg fetal growth calculator) [8]. 
Ethics
Approval for this retrospective cohort study was given by the local Helsinki 
Committee prior to the initiation of data collection, reference no. 0042-18-NHR. All 
procedures were in accordance with the requirements of the Declaration of Helsinki.
Statistics  
Statistical analysis was conducted by the statistical department at Galilee 
Medical Center using SPSS software (IBM SPSS Statistics version 25.0). Continuous 
variables are presented as the mean ± standard deviation or as median and range. 
Qualitative variables are presented as Frequencies and percentages. Comparisons of 
continuous variables between the groups were performed with an independent sample 
t-test or a Mann-Whitney test (according to the sample size of the groups and the 
variables' distribution shape). Categorical variables were analyzed using a Pearson’s 
chi-square test or Fisher’s exact test (if expectancy < 5). The prevalence of ICP was 
compared with findings of previous Israeli studies using Binomial Test. A two tailed p
value < 0.05 was considered statistically significant.
RESULTS
Out of a total of 25,379 deliveries during the study period, there were 148 
diagnosed cases of ICP. Another 128 cases were excluded due to non-definitive 
diagnosis of ICP or missing information regarding pregnancy outcome.
Of the 148 ICP cases, there were 20 (13.5%) twin pregnancies. Mean maternal
age was 29.5 and mean gestational age at diagnosis was 35.5 weeks.
The incidence of ICP in our study population was 0.58% (148 cases out of 
25,379 deliveries).
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We found a higher ICP incidence in our cohort compared with other reports 
arising from Central Israel (6) (0.58% compared with 0.36%, p < 0.001). 
The clinical characteristics of our study population are presented in Table 1. 
ICP incidence and outcomes according to ethnical groups
The incidence of ICP among Jewish and Druze patients was similar (0.69% 
and 0.62%, respectively). We found a lower ICP incidence among Muslim patients 
(0.4%). Compared with the other ethnic groups, the Christian patients had a higher 
incidence of ICP (1.1%, p = 0.005) (Tab. 2).
Maternal characteristics and outcomes of the different ethnical groups are 
shown in Table 3. 
The mean maternal age at the time of diagnosis was similar in the Jewish, 
Christian and Muslim groups (30.37, 30.15 and 29.56 years, respectively). On the 
other hand, a lower maternal age of 26 years was found in the Druze group (p = 
0.012).  No difference was found in gravidity, parity, mode of conception or multiple 
pregnancy rates between the group. Mean fasting BA levels and ALT levels were 
comparable. 
No difference in mean maternal age at diagnosis or at delivery was observed 
between the groups.
Higher incidence of PET (23.1%) was found in the Christian group compared 
with the other groups (3.2% Jews, 0% Arab Muslims, 3.8% Druze) (p = 0.013). No 
difference was observed in rates of oligohydramnios, polyhydramnios or gestational 
diabetes between the groups.
Mode of delivery and fetal gender were similar between the groups. Fetal 
weight was lower in the Christian group (2554.2 grams) (p = 0.088), but no difference
was found in the SGA rates. No cases of 5-minutes Apgar less than 7 or perinatal 
death were found.
Higher rate of NICU admissions was found in the Arab Muslim and Christian 
groups (39.5% and 47.1%, respectively) compared with the Jewish and Druze groups 
(17.5% and 14.3%, respectively) (p = 0.007).
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Preterm delivery (whether iatrogenic or spontaneous), PPH, meconium-stained
amniotic fluid and non-reassuring fetal monitoring rates were not different between 
the four ethnic groups. 
Obstetrical outcome according to the ICP severity
According to fasting BA levels (mild, fasting BA < 40 μmol/L and severe, BA 
≥ 40 μmol/L) a subgroup analysis was performed. One hundred seven patients 
consisted the mild group, while 41 patients had severe ICP (Tab. 4). 
Median ALT was significantly higher in the severe group compared with the 
mild group (79 versus 22 U/L, p < 0.001). A higher rate of PET was found in the 
severe group (14.6% versus 0%, p < 0.001). No difference was observed in rates of 
oligohydramnios, polyhydramnios or gestational diabetes between the groups.
Although not statistically significant, the median age at diagnosis was earlier 
in the severe ICP group (35.85 versus 36.85 weeks, p = 0.095). In addition, earlier 
gestational age at delivery was found in the severe group compared with the mild 
group (37 versus 38.14 weeks, p < 0.001). Although the mode of delivery was 
comparable between the two groups, a higher rate of induced vaginal delivery was 
found in the mild group (84.8% versus 64%, p = 0.01). Higher rates of iatrogenic 
preterm deliveries and meconium-stained amniotic fluid were found in the severe ICP 
group.
Birth weight was significantly lower in the severe ICP group (2689.72 versus 
2945.2 grams, p = 0.018).
No correlation was found between ICP severity and neonatal emergency 
department (ED) visits during the neonatal period. 
DISCUSSION
We found a higher ICP incidence in our cohort compared with other reports 
arising from the center of Israel (0.58% compared with 0.36%, p < 0.001) [6]. 
Furthermore, among our ethnically heterogenous study population, a higher ICP 
incidence was found in the Arab Christian group (1.11%) and a lower incidence in the 
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Arab Muslim group (0.4%) compared with the Jewish (0.69%) and Druze (0.62%) 
groups. 
The exact pathogenesis of ICP is not known, but likely involves genetic, 
hormonal, immunological and environmental factors. Previous Israeli studies on ICP 
were conducted in Rabin Medical Center in Petach-Tikva [6] and Sourasky Medical 
Center in Tel Aviv [7], both located in Central Israel and ethnical differences were not 
explored. We believe that unlike our cohort (which consisted of over 50% non-Jewish 
patients), and according to the demographics of Central Israel, the vast majority of 
Raz and Mor cohorts [6, 7] consisted of Jews. Our findings could be explained by the 
diverse genetic backgrounds of the different ethnic groups, although other factors 
such lifestyle factors may play a role and cannot be ruled out.
 
Inter-group comparison reveals a significantly lower maternal age at ICP 
diagnosis in the Druze group (mean age of 26 years) compared with the other groups. 
The Druze maternal average age at birth according to the Israeli Central Bureau of 
statistics is 28.5–29.5 years during the years 2013–2018 [9]. This finding raises the 
questions of whether Druze patients might suffer from ICP at an earlier maternal age 
and whether patient age affect ICP incidence. Others have reported that ICP is more 
prevalent in older women [10].
We found a significantly higher PET rate in the Arab Christian group (23.11%)
compared with others, and a trend toward a lower gestational age at diagnosis and a 
lower birthweight. Previous studies have reported that ICP is associated with an 
increased risk for PET, and earlier diagnosis of ICP was associated with higher 
incidence of PET [6]. Recent study found that early-onset ICP is associated with a 
lower birth weight than late-onset ICP [11].
In line with earlier research [12], we found a higher GDM prevalence in our 
study cohort (14.9%) compared with a recent Israeli report of 3.9% [13]. In animal 
modality studies BA was demonstrated to take part in glucose and lipid metabolism 
[14]. FXR, a primary BA receptor, has a regulatory role in both the glucose and 
cholesterol homeostasis [15]. 
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More neonates in the Arab Christian and Muslim groups have been admitted to
NICU which may be explained in part by the lower birth weight in the Arab Christian 
group and higher GDM rate in the Arab Muslim group. 
In addition, a comparison was made between severe and mild ICP based on 
BA levels as mentioned earlier in the methods section. In the severe group, ICP 
diagnosis was made at an earlier gestational age. Previous study reported a trend for 
less severe BA levels when the ICP diagnosis was made closer to term [16].  Although
it has been speculated that pruritis is a result of bile acids accumulation in the 
interstitial fluid of the skin and higher BA levels may lead to an earlier diagnosis, 
former studies have not found a correlation between pruritis and BA levels. 
Furthermore, some studies have reported that pruritus might precede the onset of 
biochemical abnormalities [17].
We found an elevated PET rate and meconium-stained amniotic fluid in the 
severe ICP group. In addition, the lower birthweight in this group might be attributed 
to the earlier gestational age at delivery; those findings are consistent with previous 
studies [6].
Strengths and limitations
To our knowledge, this is the first Israeli study exploring ICP incidence and 
characteristics in the different Israeli ethnical groups. Another strength of our study 
lies in it being a single-center study, with a uniform practice, treatment and clinical 
care. Furthermore, cases which were included followed strict criteria for ICP 
diagnosis, as only cases with pruritis and elevated fasting BA levels. Other etiologies 
had been excluded through carefully taken history and comprehensive physical 
examination while upper abdomen sonography was performed if needed.  Despite the 
retrospective study nature, maternal and neonatal outcomes are well documented.
Our study is not without its limitations, foremost, due to its retrospective 
design and small cohort size, while confounding bias is impossible to eliminate. In 




In conclusion, we found a higher ICP prevalence in our Northern Israeli cohort
compared with previous reports from Central Israel, a higher ICP incidence among 
Arab Christian patients and a lower incidence in the Arab Muslim group. In line with 
previous studies, severe ICP is associated with certain pregnancy complications. 
Further research is required to investigate reasons for the increased incidence 
of ICP in certain ethnical groups and to explore mechanisms responsible for the 
association between ICP, GDM and PET.
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Table 1. Clinical characteristics of the general study population
ICP cases (N = 148)
Pregnancy 
complications, n (%)




Gestational age at 
delivery, weeks, mean 
(± SD)
37.5 ± 2.1



















Iatrogenic preterm delivery 27 (18.2)










5-min Apgar < 7 0 (0)
Cord around the neck 8 (4.8)
True knot of cord 2 (1.2)
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Respiratory morbidity 16 (10.1)
SGA 2 (1.2)




ICP — intrahepatic cholestasis of pregnancy; PPH — postpartum hemorrhage; SGA 
— small for gestational age; NICU — neonatal intensive care unit




Total no. of 
deliveries in the 
Galilee Medical 
Center
Incidence of ICP 
(%)
Jew, n (%) 62 (41.9) 8890 (35.0) 0.69
Arab Muslims, n 
(%) 
41 (27.7) 10,095 (39.7) 0.4
Arab Christians, n 
(%)
26 (17.6) 4175 (16.4) 1.11
Druze, n (%) 13 (8.8) 1167 (4.5) 0.62
Missing data on 
ethnicity
6 (4.0) 1052 (4.1) 0.57
Total 148 25,379 0.58













Maternal age, years, 
mean (± SD)
30.3 ± 5.6 29.5 ± 6.5 26 ± 4.2 30.1 ± 5.5 0.01









ALT, mean (range) 24 (6–619) 48 (6–339) 34.5 (6–
200.4)
121 (6–330) 0.16









Preeclampsia 3.2 (2) 0 (0) 3.8 (1) 3 (23.1) 0.013
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Vaginal delivery, % (n) 50 (31) 63.4 (26) 69.2 (18) 53.8 (7) 0.68
Spontaneous 19.4 (6) 15.4 (4) 27.8 (5) 14.3 (1)
Induced 80.7 (25) 76.9 (20) 72.2 (13) 85.7 (6)
Instrumental 0 (0) 7.7 (2) 0 (0) 0 (0)
Cesarean delivery, % 
(n)
50 (31) 36.6 (15) 30.7 (8) 46.1 (6) 0.97
Elective 19.4 (6) 20 (3) 12.5 (1) 0 (0)
Non-elective 25.8 (8) 20 (3) 25 (2) 33.3 (2)









2554.2 ± 476.7 0.08
Labor-related complications, % (n)
Iatrogenic preterm 
delivery
16.1 (10) 14.6 (6) 19.2 (5) 38.5 (5) 0.27
Spontaneous preterm 
delivery
32. (2) 7.3 (3) 11.5 (3) 7.7 (1) 0.37
PPH 6.5 (4) 7.3 (3) 0 (0) 15.4 (2) 0.54
Meconium-stained 
amniotic fluid
4.8 (3) 14.6 (6) 19.2 (5) 5.9 (1) 0.11
Non-reassuring fetal 
monitoring
13.4 (9) 15.2 (7) 10 (3) 5.9 (1) 0.82
Newborn related complications, % (n)
Respiratory morbidity 9.5 (6) 11.6 (5) 10.7 (3) 11.8 (2) 0.96
SGA 0 (0) 2.1 (1) 3.3 (1) 0 (0) 0.42
NICU admission 17.5 (11) 39.5 (17) 14.3 (4) 47.1 (8) 0.007
5-min Apgar < 7 0 (0) 0 (0) 0 (0) 0 (0)
Perinatal death, % (n) 0 (0) 0 (0) 0 (0) 0 (0)
ALT — alanine aminotransferase; GA — gestational age; PPH — postpartum 
hemorrhage; SGA — small for gestational age; NICU — neonatal intensive care unit







Maternal age, years, mean (± SD) 29.4 ± 5.6 29.8 ± 6.3 0.69
Ethnicity, % (n)
Jews 79 (49) 21 (13) 0.21
Arab Muslims 63.4 (26) 36.6 (15)
Druze 73.1 (19) 26.9 (7)
Arab Christians 61.5 (8) 38.5 (5)
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Bile acids, mean (range) 14.8 (10–36) 71.9 (41–184.8) –
ALT, mean (range) 22 (6–313) 79 (6–619) < 0.001
GA at diagnosis, weeks, mean (range) 36.8 (25–41.2) 35.8 (29.4–39.7) 0.09
Preeclampsia 0 (0) 14.6 (6) < 0.001
GA at delivery, weeks, mean (± SD) 38.1 (28.2–41.4) 37 (32.1–40.1) < 0.001
Mode of delivery
Vaginal delivery, % (n) 55.1 (59) 60.9 (25) 0.01
Spontaneous 13.6 (8) 32 (8)
Induced 84.8 (50) 64 (16)
Instrumental 1.7 (1) 4 (1)
Cesarean delivery, % (n) 44.8 (48) 39.0 (16) 0.71
Elective 18.8 (9) 12.5 (2)
Non-elective 20.8 (10) 31.3 (5)
Emergency 60.4 (29) 56.3 (9)
Birthweight, grams, mean (± SD) 2945.2 ± 657 2689 ± 520.4 0.018
Labor-related complications, % (n)
Iatrogenic preterm delivery 15.9 (17) 24.4 (10) 0.24
Spontaneous preterm delivery 3.7 (4) 12.2 (5) 0.11
PPH 4.7 (5) 7.3 (3) 0.68
Meconium-stained amniotic fluid 7.5 (8) 19.5 (8) 0.07
Non-reassuring fetal monitoring 11.7 (14) 12.8 (6) 1.0
Newborn related complications, % (n)
Respiratory morbidity 12.5 (14) 4.3 (2) 0.15
SGA 0.8 (1) 2.1 (1) 0.48
NICU admission 24.1 (27) 32.6 (15) 0.32
ALT — alanine aminotransferase; GA — gestational age; PPH — postpartum 
hemorrhage; SGA — small for gestational age; NICU — neonatal intensive care unit
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